CHARLESTON, W.Va. — Medical device giant C.R. Bard is settling the case that was selected to serve as the bellwether trial in the federal multidistrict litigation for thousands of transvaginal mesh cases.

Debra Wise’s lawsuit against C.R. Bard for her injuries suffered by the company’s dangerous transvaginal mesh was selected to be the bellwether trial in the U.S. District Court for the Southern District of West Virginia. Bellwether trials act like a test for all of the other cases in the multidistrict litigation panel, where over 70,000 transvaginal mesh cases wait to be heard. On February 18th, Judge Goodwin removed the case from the court’s active docket after receiving notification of a pending settlement from the party’s counsel.

The settlement signifies a first for C.R. Bard as it faces thousands of transvaginal mesh cases, not only in front of Judge Goodwin, but in multiple state courts as well. This decision comes after the judge urged all of the companies to resolve to settle the thousands of cases as quickly as possible or risk losing multiple multi-million dollar settlements.

Purpose of Transvaginal Mesh

Transvaginal mesh was first introduced in the late 1990s as an innovative and easy way to treat incontinence and pelvic organ prolapse in women. It is a synthetic netting that is implanted into the body to support the pelvic muscles. Unfortunately, it not only can cause pelvic organ prolapse, but when the mesh erodes or migrates out of place it can cause organ perforation, infection, tissue scarring, and incontinence.

C.R. Bard created multiple transvaginal mesh product lines, including Pelvilace, Pelvitex, Pelvisoft BioMesh, Pelvicol Acellular, Collagen Matrix, and Avaulta. The Avaulta Plus Mesh is the one that has been hit with the most lawsuits, but all of the company’s mesh devices have been associated with serious health issues.

With thousands of cases sitting in federal district court and the company facing huge verdicts in state court, the decision to settle is an unsurprising one. Despite the obvious logic in settling, very few transvaginal mesh companies have done so. Endo International’s subsidiary American Medical System was one of the first to reach a settlement agreement. The company has agreed to set aside up to $1.6 billion to resolve up to 20,000 pending transvaginal mesh lawsuits.

The Transvaginal Mesh No Fee Promise

If you or a loved one has been harmed by transvaginal mesh, you may have a claim against the manufacturer. Our award winning attorneys specialize in filing lawsuits for people who have been wronged by serious side-effects of prescription medications and defective medical devices. We operate under our No Fee Promise, which means you will not pay a dime until your case has been accepted and you receive your settlement. We will put it in writing for you.

To get started on your case, simply call our offices any time of the day at (866) 280-4722 or fill out the Free Case Review Form on the side of this page. We will listen to your story, explain what rights you have, and determine if you have a potential lawsuit against the device manufacturer. Remember, there are strict time deadlines to filing defective drug and device claims and if you do not act quickly your claim will be lost forever.

  • Was this information helpful?
  • Yes   No